Shopping Cart
- Remove All
- Your shopping cart is currently empty
Norepinephrine (Levophed) can stimulate apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. It can up-regulate the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumour cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | $41 | In Stock | |
1 mL x 10 mM (in DMSO) | $50 | In Stock |
Description | Norepinephrine (Levophed) can stimulate apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. It can up-regulate the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumour cells. |
Targets&IC50 | β1-adrenoceptor:740 nM (Ki), α2A-adrenoceptor:56 nM (Ki), α1-adrenoceptor:330 nM (Ki) |
In vitro | METHODS: Adult hippocampal cells were treated with Norepinephrine (0.1-10 µM) for 10-13 days and the number of neurospheres was determined using classical neurosphere assay. RESULTS: A significant increase in the number of neurospheres was obtained at 100 nm and in the presence of 1 µM Norepinephrine, and a twofold increase in the number of neurospheres was observed in the presence of 10 µM Norepinephrine. [1] METHODS: Human pancreatic cancer cells BxPC-3 and Panc-1 were treated with Norepinephrine (10 µM) for 12-48 h. Cell viability was assayed by MTT Assay. RESULTS: Norepinephrine treatment alone significantly enhanced the viability of PDAC cells. [2] |
In vivo | METHODS: To test in vivo activity, Norepinephrine (0.2-2 mg/kga) was administered intraperitoneally to C57BL6/J mice fed a high-fat diet once daily for two weeks. RESULTS: A subset of Norepinephrine-treated mice developed unexpected adverse events, including bladder dilatation and decreased renal perfusion due to renal discoloration. [3] |
Alias | Nor-Epirenan, L-Noradrenaline, Levophed, Levonoradrenaline, Levonor, Arterenol, Aktamin |
Molecular Weight | 169.18 |
Formula | C8H11NO3 |
Cas No. | 51-41-2 |
Smiles | [C@@H](CN)(O)C1=CC(O)=C(O)C=C1 |
Relative Density. | 1.397 g/cm3 |
Storage | keep away from direct sunlight,keep away from moisture,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | 0.1M HCl: 10 mg/mL (59.11 mM), Sonication is recommended. ![]() H2O: < 1 mg/mL (Insoluble) ![]() DMSO: 8.46 mg/mL (50.01 mM), Sonication and heating are recommended. ![]() | ||||||||||||||||||||||||||||||
In Vivo Formulation | 10% DMSO+90% Saline: 0.1 mg/mL (0.59 mM), Solution. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.![]() | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO/0.1M HCl
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.